Trials / Completed
CompletedNCT02456337
Xenogenous Collagen Matrix Graft With or Without Enamel Matrix Proteins Derivative for Root Coverage
Xenogenous Collagen Matrix Graft Associated or Not With Enamel Matrix Derivative Proteins in the Treatment of Gingival Recession Class I and II of Miller: Randomized Controlled Clinical Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- University of Campinas, Brazil · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the reduction of gingival recession of single Miller Class I and II defects treated by coronally advanced flap with subepithelial porcine collagen matrix graft and / or enamel matrix proteins.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Mucograft | Coronally advanced flap associated to Xenogenous collagen matrix graft (mucograft) for the treatment of gingival recessions Miller Class I or II. |
| DEVICE | Emdogain | Coronally advanced flap associated to Enamel Matrix Derivative (Emdogain) for the treatment of gingival recessions Miller Class I or II. |
| PROCEDURE | Coronally Advanced flap | Coronally advanced flap for the treatment of gingival recessions Miller Class I or II. |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2016-09-01
- Completion
- 2016-10-01
- First posted
- 2015-05-28
- Last updated
- 2016-10-27
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT02456337. Inclusion in this directory is not an endorsement.